No data to show
OTCM
EXOSF
Market cap2.22bUSD
Dec 14, Last price
43.64USD
Name
Exosens SAS
Chart & Performance
P/E
63.94
P/S
4.98
EPS
0.60
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
394m
+23.62%
Net income
31m
+79.11%
CFO
96m
+90.63%
Profile
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2024‑12 | 2023‑12 | |
| Income | ||
Revenues | 394,100 23.62% | 318,796 |
Cost of revenue | 168,500 | 226,492 |
Unusual Expense (Income) | ||
NOPBT | 225,600 | 92,304 |
NOPBT Margin | 57.24% | 28.95% |
Operating Taxes | 11,100 | 1,798 |
Tax Rate | 4.92% | 1.95% |
NOPAT | 214,500 | 90,506 |
Net income | 30,700 79.11% | 17,140 |
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | 179,700 | |
BB yield | ||
| Debt | ||
Debt current | 2,700 | 7,821 |
Long-term debt | 19,100 | 313,999 |
Deferred revenue | ||
Other long-term liabilities | 268,600 | 38,317 |
Net debt | (99,700) | 272,842 |
| Cash flow | ||
Cash from operating activities | 96,200 | 50,464 |
CAPEX | (30,938) | |
Cash from investing activities | (72,700) | (99,643) |
Cash from financing activities | 76,300 | 35,492 |
FCF | 188,972 | |
| Balance | ||
Cash | 150,200 | 44,824 |
Long term investments | (28,700) | 4,154 |
Excess cash | 101,795 | 33,038 |
Stockholders' equity | 21,600 | 16,013 |
Invested Capital | 670,500 | 538,136 |
ROIC | 35.49% | 16.82% |
ROCE | 31.65% | 16.66% |
| EV | ||
Common stock shares outstanding | 50,783 | 30,387 |
Price | ||
Market cap | ||
EV | ||
EBITDA | 262,500 | 92,304 |
EV/EBITDA | ||
Interest | 30,784 | |
Interest/NOPBT | 33.35% | |